FDA recall, , Low risk
Blood Assurance Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were distributed without a label indicating they contained antibodies.
Recall ended Sep 24, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Blood Assurance Inc began a recall of one unit of Red Blood Cells, Leukocytes Reduced on May 30, 2025, because the product was distributed without a label indicating it contained antibodies. The FDA added the recall to its Enforcement Report on September 24, 2026, and classified it the same day. The product was distributed in Georgia.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Blood Assurance Inc
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99134
- Recall number
- B-0212-2026
- Quantity recalled
- 1 unit
All recalls from Blood Assurance Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
